Figure S1. The effect of VCR or Epirubicin on RMS cells in vitro. (A) RMS cell lines were treated with VCR for 72âh. Cell confluency(%) was calculated using Incucyte Zoom software by phase-contrast images. Each data point represents the mean, SD of triplicate wells. (B) RMS cell lines were treated with Epirubicin for 72âh. Cell confluency(%) was calculated using Incucyte Zoom software by phase-contrast images. Each data point represents the mean, SD of triplicate wells. (TIF 858 kb
Cell proliferation assays in DU145/FAM3B cells (A) Viable DU145/FAM3B and DU145-control cells were h...
Viability analysis of U-87 MG cells. Cells were treated with variable concentrations of D11 for the ...
Figure S2. Anti-proliferative effect of RAD001 in combination with endocrine agents (a) 4-OHT and (b...
Figure S2. The combination effect of DMAMCL with VCR or Epirubicin on RMS cells in vitro. (A) RD and...
FigureS3. The weight of RMS tumor bearing mice was no change during DMAMCL treatment. RD (n = 9), RH...
Figure S1. Phosphohistone H3 (pHH3) expression and rhabdomyoblast count in VCR and ENT + VCR-treated...
Figure S1. The combination effect of MPT0G211 and chemotherapeutic agent on acute leukemia cell line...
Brivaracetam and lacosamide treatments induces accumulation of cells in G0/G1. a-b) Distribution of ...
Additional file 2: Figure S1. Effects of different chemotherapeutic drugs on Jurkat cell proliferati...
Additional file 1: Figure S1. S9 binds MDM2 in Renca cells. Addition of 100 μM S9 to Renca cells fol...
Additional file 1: Figure S1. Schematic diagram of the synthetic route of CSC polymer. Figure S2. 1H...
Table S1. Sensitivity of TNBC cells to PI3K/mTOR inhibitors. HCC38 cells and MDA-MB-231 cells were t...
(A/B) Ba/F3 vector cells and cells transformed with pBABE Bcr-Abl were exposed to the indicated inhi...
MEDI3039 induces cell death in TNBC cell lines. (A) Western blot showing time-dependent effect of ME...
CA inhibits ERBB2− in vitro breast cancer cell survival and migration. MCF7 and MDA-MB-231 cells wer...
Cell proliferation assays in DU145/FAM3B cells (A) Viable DU145/FAM3B and DU145-control cells were h...
Viability analysis of U-87 MG cells. Cells were treated with variable concentrations of D11 for the ...
Figure S2. Anti-proliferative effect of RAD001 in combination with endocrine agents (a) 4-OHT and (b...
Figure S2. The combination effect of DMAMCL with VCR or Epirubicin on RMS cells in vitro. (A) RD and...
FigureS3. The weight of RMS tumor bearing mice was no change during DMAMCL treatment. RD (n = 9), RH...
Figure S1. Phosphohistone H3 (pHH3) expression and rhabdomyoblast count in VCR and ENT + VCR-treated...
Figure S1. The combination effect of MPT0G211 and chemotherapeutic agent on acute leukemia cell line...
Brivaracetam and lacosamide treatments induces accumulation of cells in G0/G1. a-b) Distribution of ...
Additional file 2: Figure S1. Effects of different chemotherapeutic drugs on Jurkat cell proliferati...
Additional file 1: Figure S1. S9 binds MDM2 in Renca cells. Addition of 100 μM S9 to Renca cells fol...
Additional file 1: Figure S1. Schematic diagram of the synthetic route of CSC polymer. Figure S2. 1H...
Table S1. Sensitivity of TNBC cells to PI3K/mTOR inhibitors. HCC38 cells and MDA-MB-231 cells were t...
(A/B) Ba/F3 vector cells and cells transformed with pBABE Bcr-Abl were exposed to the indicated inhi...
MEDI3039 induces cell death in TNBC cell lines. (A) Western blot showing time-dependent effect of ME...
CA inhibits ERBB2− in vitro breast cancer cell survival and migration. MCF7 and MDA-MB-231 cells wer...
Cell proliferation assays in DU145/FAM3B cells (A) Viable DU145/FAM3B and DU145-control cells were h...
Viability analysis of U-87 MG cells. Cells were treated with variable concentrations of D11 for the ...
Figure S2. Anti-proliferative effect of RAD001 in combination with endocrine agents (a) 4-OHT and (b...